Mitchell P. Kopin 13D/13G Filings for BioLineRx Ltd. (BLRX)

Mitchell P. Kopin 13D and 13G filings for BioLineRx Ltd.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2025-01-10
6:51 pm
Purchase		2025-01-0613GBioLineRx Ltd.
BLRX		Mitchell P. Kopin2,555,903
4.990%		2,077,581increase
(+434.35%)		Filing
2020-06-04
7:06 pm
Purchase		2020-05-2613GBioLineRx Ltd.
BLRX		Mitchell P. Kopin478,322
6.100%		478,322increase
(New Position)		Filing